Engineers and develops therapeutic protease products
South San Francisco, CA
Contact: Jeff Himawan
www.catalystbiosciences.com
Pfizer Initiates Phase 1 Clinical Trial for FVIIa Hemophilia Drug Candidate Developed by Catalyst Biosciences
Catalyst Biosciences Receives Milestone Payment from Pfizer for Progress in Lead Hemostasis Program
Catalyst Biosciences Announces Agreement with MedImmune to Develop Engineered Protease Therapeutics
Catalyst Biosciences and Wyeth Pharmaceuticals Announce Worldwide Collaboration
Catalyst Biosciences Raises $40M in Series C Financing
